Abstract:BackgroundFibroblastic foci are characteristic features in lung parenchyma of patients with idiopathic pulmonary fibrosis (IPF). They comprise aggregates of mesenchymal cells which underlie sites of unresolved epithelial injury and are associated with progression of fibrosis. However, the cellular origins of these mesenchymal phenotypes remain unclear. We examined whether the potent fibrogenic cytokine TGF-β1 could induce epithelial mesenchymal transition (EMT) in the human alveolar epithelial cell line, A549, and investigated the signaling pathway of TGF-β1-mediated EMT.MethodsA549 cells were examined for evidence of EMT after treatment with TGF-β1. EMT was assessed by: morphology under phase-contrast microscopy; Western analysis of cell lysates for expression of mesenchymal phenotypic markers including fibronectin EDA (Fn-EDA), and expression of epithelial phenotypic markers including E-cadherin (E-cad). Markers of fibrogenesis, including collagens and connective tissue growth factor (CTGF) were also evaluated by measuring mRNA level using RT-PCR, and protein by immunofluorescence or Western blotting. Signaling pathways for EMT were characterized by Western analysis of cell lysates using monoclonal antibodies to detect phosphorylated Erk1/2 and Smad2 after TGF-β1 treatment in the presence or absence of MEK inhibitors. The role of Smad2 in TGF-β1-mediated EMT was investigated using siRNA.ResultsThe data showed that TGF-β1, but not TNF-α or IL-1β, induced A549 cells with an alveolar epithelial type II cell phenotype to undergo EMT in a time-and concentration-dependent manner. The process of EMT was accompanied by morphological alteration and expression of the fibroblast phenotypic markers Fn-EDA and vimentin, concomitant with a downregulation of the epithelial phenotype marker E-cad. Furthermore, cells that had undergone EMT showed enhanced expression of markers of fibrogenesis including collagens type I and III and CTGF. MMP-2 expression was also evidenced. TGF-β1-induced EMT occurred through phosphorylation of Smad2 and was inhibited by Smad2 gene silencing; MEK inhibitors failed to attenuate either EMT-associated Smad2 phosphorylation or the observed phenotypic changes.ConclusionOur study shows that TGF-β1 induces A549 alveolar epithelial cells to undergo EMT via Smad2 activation. Our data support the concept of EMT in lung epithelial cells, and suggest the need for further studies to investigate the phenomenon.

Trans-differentiation of Alveolar Epithelial Type II Cells to Type I Cells Involves Autocrine Signaling by Transforming Growth Factor Β1 Through the Smad Pathway

Involvement of Multiple Transcription Factors in Regulation of IL-β-induced MCP-1 Expression in Alveolar Type II Epithelial Cells.

Tnf-Alpha Induction Of Il-6 In Alveolar Type Ii Epithelial Cells: Contributions Of Jnk/C-Jun/Ap-1 Element, C/Ebp Delta/C/Ebp Binding Site And Ikk/Nf-Kappa B P65/Kappa B Site

TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

Epithelial-mesenchymal Transition of Type Ⅱ Alveolar Epithelial Cells Induced by TGF-β1

Alveolar Type Ii Cells Possess The Capability Of Initiating Lung Tumor Development

The Effect of TGF-β1 and Smad7 Gene Transfer on the Phenotypic Changes of Rat Alveolar Epithelial Cells

MicroRNA-375 Regulates Alveolar Epithelial Cell Trans-Differentiation through the Wnt/{beta}-catenin Pathway

Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis

TGF-β Type I Receptor/alk-5 and Smad Proteins Mediate Epithelial to Mesenchymal Transdifferentiation in NMuMG Breast Epithelial Cells

[Effect of Smad7 on Transforming Growth Factor-Beta1-induced Alveolar Epithelial to Mesenchymal Transition].

Glycogen Synthase Kinase‐3β Promotes Radiation‐induced Lung Fibrosis by Regulating Β‐catenin/lin28 Signaling Network to Determine Type II Alveolar Stem Cell Transdifferentiation State

Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis

Focal Adhesion Kinase Signaling Determines the Fate of Lung Epithelial Cells in Response to TGF-β.

Effect of TGF-β1 and EGF on the Phenotypical Change and Function of Type Ⅱ Alveolar Epithelial Cells

Regulatory Mechanisms of TGF‐β1‐induced Fibrogenesis of Human Alveolar Epithelial Cells

TGF-β controls alveolar type 1 epithelial cell plasticity and alveolar matrisome gene transcription in mice

Whole-Genome Analysis of Temporal Gene Expression during Early Transdifferentiation of Human Lung Alveolar Epithelial Type 2 Cells In Vitro

Transforming growth factor-β1 and SMAD signalling pathway in the small airways of smokers and patients with COPD: potential role in driving fibrotic type-2 epithelial mesenchymal transition

TGF-Beta Receptor II Is Critical for Osteogenic Progenitor Cell Proliferation and Differentiation During Postnatal Alveolar Bone Formation

Downregulation of β-Catenin Contributes to type II Alveolar Epithelial Stem Cell Resistance to Epithelial-Mesenchymal Transition by Lowing Lin28/let-7 Ratios in Fibrosis-Resistant Mice after Thoracic Irradiation